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Abstract
Celiac Disease is a type IV hypersensitive response to gluten caused by HLA-DQ2 or
HLA-DQ8 T-cell presentation, initiating destruction of intestinal epithelial cells.
Currently, the only remedy for those suffering from celiac disease is the complete
elimination of all gluten from the diet. Studies indicate that an indigestible fragment of
the gluten molecule, alpha-gliadin subcomponent 33-mer, rich in proline and
glutamine, is responsible for the hypersensitivity response. Determination of 33-mer
concentration in wheat lines could be beneficial to the future development of wheat
lines with reduced 33-mer concentration. In this study, gliadin protein from wheat
flour was extracted and separated from other proteins of wheat flour. The extract of
gliadin was then subjected to enzyme-linked immunosorbent assay (ELISA) technique
in order to quantify the concentration of the 33-mer fragment. This is the critical nextstep in allowing us to identify and develop wheat lines with reduced concentrations of
33-mer. It is possible that wheat with reduced 33-mer may be suitable for consumption
by individuals with celiac disease.

Material and Methods
Previously, the protein concentration in the wheat flour extraction samples was
confirmed through a serial dilution of the protein extract with 4 sample concentrations
at 1mg/mL, 100 µg/mL, 10µg/mL, and 1µg/mL. Enzyme-Linked Immunosorbent
Assay (ELISA) was used to specially tag the protein of interest, 33-mer, and confirm
the concentration gradient. In the first stage of this process a sample of wheat flour
was compared to a gliadin standard. Using 1 mL extracted gliadin, a series of dilution
were performed using coding buffer. Following the dilutions, the samples were
incubated in a dark refrigerator overnight. The wells were then aspirated and washed
with PBS/Tween-20. 0.5% blocking buffer and allowed to rest overnight. Primary
antibody (anti-gliadin) was diluted with 0.5% blocking buffer at a ratio of 1μL:10mL,
and after repeated dilutions into ELISA wells, the plates were incubated for two hours
at room temperature (37°C). The following day, the plates were aspirated and washed
with PBS/Tween, diluted with the secondary antibody (Anti-Mouse-HRP) in blocking
buffer at 1μL:5mL. The secondary antibody was then added to the ELISA wells for
one hour at room temperature. After removing the liquid, the substrate was added
(50mL:50mL:1μL) to each well. The ELISA plate was then visualize on the Glomax
Microliter Plate

Conclusion
The gliadin protein was successfully isolated and used to create a serial dilution series.
ELISA was then used to identify the 33- mer fragment of interest. Refinement of this
procedure is required to successfully quantify the concentration 33-mer in each sample.

Future Research
Further research needs to be conducted in order to refine the protocol for detection of
the presence of the 33-mer concentration in wheat flour. This will allow screening of
multiple wheat lines, and determination of genetic diversity for breeding and selection.
This could lead to the development of a wheat line containing reduced 33-mer
concentrations, which may be safe for individuals with CD to consume without the
adverse health effects of traditional gluten products.

Results and Discussion
The ELISA results were not highly correlated with the expected linear range of
concentrations within the seven serial dilutions. Decreasing ELISA signal would be
expected to be associated with decreasing protein concentration. The unexpected data
may be due to low levels of analyte concentrations established in the wells. The next
samples are proposed to have a higher analyte concentration in an effort to correct the
problem.

Introduction
Table 1: ELISA 4 Test Data
Celiac Disease (CD) is a gluten hypersensitivity characterized by severe physical
symptoms caused by genetic and environmental factors. Genetically, 90-95% of CD
patient’s T-cells respond to the gluten derived peptides presented by HLA-DQ2 or
HLA-DQ8 cell surface receptors that trigger the destruction of intestinal epithelial cells
(Tian, et.al, 2015). Environmentally, CD is triggered by the ingestion of gluten, a
general term referring to to the aggregation of the storage proteins gliadin and glutenin
(Van den Broeck, et al, 2009), which are found in wheat (Triticum aestivum L.), barley
(Hordeum vulgare L.), and rye (Secale cereale L.). Gliadin is further subclassified into
alpha, beta, and gamma subcomponents. Studies indicate that an indigestible alpha
gliadin subcomponent, rich in proline and glutamine, is responsible for the
hypersensitivity response. The presence of such amino acids make this alpha-9 gliadin
subcomponent resistant to digestion by proteases, which is unaffected by normal
digestion (Hollon, et al, 2015). Studies show that this particular epitope of gliadin,
alpha-9, disrupts digestive processes most dramatically (van de Broek, et. al., 2009). Of
particular interest is the peptide sequence, 33-mer, that binds to the HLA-DQ complex
and then to T-cell receptors, triggering an adaptive immune response resulting in
inflammation, and ultimately death of intestinal cells, giving rise to the characteristic
symptoms of CD (Barone, et.al, 2015). Development of wheat lines with reduced 33mer may be valuable to individuals suffering from CD. Such a wheat variety may not
trigger an autoimmune response, permitting CD patients to eat gluten-containing foods
without experiencing adverse side effects.
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